EE507 Integrated Budget Impact Analysis of Introducing Selpercatinib As a Tumor-Agnostic Treatment Option for Patients with RET-Altered Solid Tumors in the United States

Saved in:
Bibliographic Details
Published inValue in health Vol. 26; no. 6; p. S152
Main Authors Bhandari, N.R., Cinfio, F.N., Gilligan, A., Myers, J., Ale-Ali, A., Smolen, L.
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.06.2023
Online AccessGet full text

Cover

More Information
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2023.03.2486